-
2024-514850-59-00
Appendicitis 5 2025-02-24
-
2024-510772-20-00
Rectal cancer locally advanced with microsatellite unst 4 2025-02-06
-
2024-513406-59-00
Inguinal hernia open surgery recovery 5 2025-02-05
-
2024-513352-15-00
Portal hypertension 4 2025-02-04
-
2024-519825-39-00
Locally advanced colon cancer (LACC) 4 2025-01-30
-
2024-515756-20-00
Functional Dyspepsia 5 2025-01-30
-
2023-508234-34-00
Crohn's disease 4 2025-01-27
-
2022-503027-10-00
Crohn's disease 9 2025-01-21
-
2024-513598-33-00
Disseminated cancer 6 2025-01-21
-
2023-504554-35-00
incisional hernia 5 2025-01-17
-
2024-514129-43-00
Metastatic pancreatic ductal adenocarcinoma 4 2025-01-15
-
2024-513004-33-00
Hepatotoxicity 4 2025-01-14
-
2024-512798-29-00
Male and female patients aged ≥ 18 to ≤ 85 years with a 5 2025-01-07
-
2024-514420-16-00
RAS/BRAF wild-type metastatic colorectal cancer 4 2024-12-18
-
2024-516709-22-00
metastatic colorectal cancer carcinoma 10 2024-12-16
-
2024-512301-16-01
Metastatic colorectal cancer 3 2024-12-12
-
2023-507773-17-00
Patients with perampullary carcinoma and a high-risk pr 4 2024-12-11
-
2024-519968-41-00
Fibrosis liber, chronic liver disease, alcoholic liver 10 2024-12-11
-
2024-511124-14-00
Postoperative obesity 7 2024-12-10
-
2024-513441-36-00
MMRp/ MSS colon cancer 4 2024-11-27
-
2024-513009-30-00
Moderate to Severe Crohn’s Disease 4 2024-11-21
-
2024-515381-14-00
heartburn and or reflux 6 2024-11-20
-
2024-511265-11-01
patients who are requested a colonoscopy for any indica 6 2024-11-19
-
2023-510217-26-00
colorectal cancer with peritoneal metastasis 3 2024-11-14